CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition
暂无分享,去创建一个
J. Hernández-Rivas | Catherine J. Wu | I. García-Tuñón | M. Gruber | A. Herrero | Shanye Yin | J. García | R. Benito | M. Hernández-Sánchez | J. M. Bastida | M. Martín-Izquierdo | J. Hernández-Sánchez | L. San Segundo | Elisa ten Hacken | A. Rodríguez-Vicente | M. Quijada-Álamo | J. Ordoñez | Verónica Alonso-Pérez | J. Bastida | Ana E. Rodríguez-Vicente